Literature DB >> 12655049

Neutral thiol as a proximal ligand to ferrous heme iron: implications for heme proteins that lose cysteine thiolate ligation on reduction.

Roshan Perera1, Masanori Sono, Jeffrey A Sigman, Thomas D Pfister, Yi Lu, John H Dawson.   

Abstract

Cysteine plays a key role as a metal ligand in metalloproteins. In all well-recognized cases, however, it is the anionic cysteinate that coordinates. Several cysteinate-ligated heme proteins are known, but some fail to retain thiolate ligation in the ferrous state, possibly following protonation to form neutral cysteine. Ligation by cysteine thiol in ferrous heme proteins has not been documented. To establish spectroscopic signatures for such systems, we have prepared five-coordinate adducts of the ferrous myoglobin H94G cavity mutant with neutral thiol and thioether sulfur donors as well as six-coordinate derivatives such as with CO and, when possible, with NO and O(2). A thiol-ligated oxyferrous complex is reported, to our knowledge for the first time. Further, a bis-thioether ferrous H93G model for bis-methionine ligation, as found in Pseudomonas aeruginosa bacterioferritin heme protein, is described. Magnetic CD spectroscopy has been used due to its established ability in axial ligand identification. The magnetic CD spectra of the H93G complexes have been compared with those of ferrous H175CD235L cytochrome c peroxidase to show that its proximal ligand is neutral cysteine. We had previously reported this cytochrome c peroxidase mutant to be cysteinate-ligated in the ferric state, but the ferrous ligand was undetermined. The spectral properties of ferrous liver microsomal cytochrome P420 (inactive P450) are also consistent with thiol ligation. This study establishes that neutral cysteine can serve as a ligand in ferrous heme iron proteins, and that ferric cysteinate-ligated heme proteins that fail to retain such ligation on reduction may simply be ligated by neutral cysteine.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12655049      PMCID: PMC152975          DOI: 10.1073/pnas.0737142100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Heme-Containing Oxygenases.

Authors:  Masanori Sono; Mark P. Roach; Eric D. Coulter; John H. Dawson
Journal:  Chem Rev       Date:  1996-11-07       Impact factor: 60.622

2.  Ligation of the iron in the heme-heme oxygenase complex: X-ray absorption, electronic absorption and magnetic circular dichroism studies.

Authors:  B K Hawkins; A Wilks; L S Powers; P R Ortiz de Montellano; J H Dawson
Journal:  Biochim Biophys Acta       Date:  1996-07-18

3.  Characterization of the coral allene oxide synthase active site with UV-visible absorption, magnetic circular dichroism, and electron paramagnetic resonance spectroscopy: evidence for tyrosinate ligation to the ferric enzyme heme iron.

Authors:  B D Abraham; M Sono; O Boutaud; A Shriner; J H Dawson; A R Brash; B J Gaffney
Journal:  Biochemistry       Date:  2001-02-20       Impact factor: 3.162

4.  Letter: Oxidized cytochrome P-450. Magnetic circular dichroism evidence for thiolate ligation in the substrate-bound form. Implications for the catalytic mechanism.

Authors:  J H Dawson; R H Holm; J R Trudell; G Barth; R E Linder; E Bunnenberg; C Djerassi; S C Tang
Journal:  J Am Chem Soc       Date:  1976-06-09       Impact factor: 15.419

5.  Replacement of the proximal histidine iron ligand by a cysteine or tyrosine converts heme oxygenase to an oxidase.

Authors:  Y Liu; P Moënne-Loccoz; D P Hildebrand; A Wilks; T M Loehr; A G Mauk; P R Ortiz de Montellano
Journal:  Biochemistry       Date:  1999-03-23       Impact factor: 3.162

6.  Ligand-switching intermediates for the CO-sensing transcriptional activator CooA measured by pulse radiolysis.

Authors:  H Nakajima; E Nakagawa; K Kobayashi; S Tagawa; S Aono
Journal:  J Biol Chem       Date:  2001-08-03       Impact factor: 5.157

7.  Engineering cytochrome c peroxidase into cytochrome P450: a proximal effect on heme-thiolate ligation.

Authors:  J A Sigman; A E Pond; J H Dawson; Y Lu
Journal:  Biochemistry       Date:  1999-08-24       Impact factor: 3.162

8.  Alteration of human myoglobin proximal histidine to cysteine or tyrosine by site-directed mutagenesis: characterization and their catalytic activities.

Authors:  S Adachi; S Nagano; Y Watanabe; K Ishimori; I Morishima
Journal:  Biochem Biophys Res Commun       Date:  1991-10-15       Impact factor: 3.575

9.  Sulfur donor ligand binding to ferric cytochrome P-450-CAM and myoglobin. Ultraviolet-visible absorption, magnetic circular dichroism, and electron paramagnetic resonance spectroscopic investigation of the complexes.

Authors:  M Sono; L A Andersson; J H Dawson
Journal:  J Biol Chem       Date:  1982-07-25       Impact factor: 5.157

10.  Preparation and properties of ferrous chloroperoxidase complexes with dioxygen, nitric oxide, and an alkyl isocyanide. Spectroscopic dissimilarities between the oxygenated forms of chloroperoxidase and cytochrome P-450.

Authors:  M Sono; K S Eble; J H Dawson; L P Hager
Journal:  J Biol Chem       Date:  1985-12-15       Impact factor: 5.157

View more
  41 in total

1.  Substrate preferences and catalytic parameters determined by structural characteristics of sterol 14alpha-demethylase (CYP51) from Leishmania infantum.

Authors:  Tatiana Y Hargrove; Zdzislaw Wawrzak; Jialin Liu; W David Nes; Michael R Waterman; Galina I Lepesheva
Journal:  J Biol Chem       Date:  2011-05-31       Impact factor: 5.157

Review 2.  Biological inorganic chemistry at the beginning of the 21st century.

Authors:  Harry B Gray
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-25       Impact factor: 11.205

3.  Ferric, not ferrous, heme activates RNA-binding protein DGCR8 for primary microRNA processing.

Authors:  Ian Barr; Aaron T Smith; Yanqiu Chen; Rachel Senturia; Judith N Burstyn; Feng Guo
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-23       Impact factor: 11.205

4.  The H93G Myoglobin Cavity Mutant as a Versatile Scaffold for Modeling Heme Iron Coordination Structures in Protein Active Sites and Their Characterization with Magnetic Circular Dichroism Spectroscopy.

Authors:  Jing Du; Masanori Sono; John H Dawson
Journal:  Coord Chem Rev       Date:  2011-04-01       Impact factor: 22.315

5.  Metalloprotein and metallo-DNA/RNAzyme design: current approaches, success measures, and future challenges.

Authors:  Yi Lu
Journal:  Inorg Chem       Date:  2006-12-11       Impact factor: 5.165

6.  Investigation of the mechanism of formation of a thiolate-ligated Fe(III)-OOH.

Authors:  Elaine Nam; Pauline E Alokolaro; Rodney D Swartz; Morgan C Gleaves; Jessica Pikul; Julie A Kovacs
Journal:  Inorg Chem       Date:  2011-02-01       Impact factor: 5.165

7.  Endogenous insertion of non-native metalloporphyrins into human membrane cytochrome P450 enzymes.

Authors:  Rahul Yadav; Emily E Scott
Journal:  J Biol Chem       Date:  2018-09-14       Impact factor: 5.157

8.  Characterization of active site structure in CYP121. A cytochrome P450 essential for viability of Mycobacterium tuberculosis H37Rv.

Authors:  Kirsty J McLean; Paul Carroll; D Geraint Lewis; Adrian J Dunford; Harriet E Seward; Rajasekhar Neeli; Myles R Cheesman; Laurent Marsollier; Philip Douglas; W Ewen Smith; Ida Rosenkrands; Stewart T Cole; David Leys; Tanya Parish; Andrew W Munro
Journal:  J Biol Chem       Date:  2008-09-24       Impact factor: 5.157

9.  A nitric oxide-binding heterodimeric cytochrome c complex from the anammox bacterium Kuenenia stuttgartiensis binds to hydrazine synthase.

Authors:  Mohd Akram; Joachim Reimann; Andreas Dietl; Andreas Menzel; Wouter Versantvoort; Boran Kartal; Mike S M Jetten; Thomas R M Barends
Journal:  J Biol Chem       Date:  2019-09-22       Impact factor: 5.157

10.  Redox and chemical activities of the hemes in the sulfur oxidation pathway enzyme SoxAX.

Authors:  Justin M Bradley; Sophie J Marritt; Margaret A Kihlken; Kate Haynes; Andrew M Hemmings; Ben C Berks; Myles R Cheesman; Julea N Butt
Journal:  J Biol Chem       Date:  2012-10-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.